Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€9.10
01.02.20
€12.00
01.10.20
-6.04%
01.10.20

melinda 
01.02.20 50%
buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€50.50
28.01.20
€55.00
04.11.21
-23.09%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
28.01.20 50%
buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€45.60
19.01.20
€55.00
04.11.21
21.49%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
19.01.20 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€127.44
17.01.20
€160.00
04.11.21
83.69%
05.11.21

stratec 
17.01.20 50%
buy
Codexis Inc.

Start price
Target price
Perf. (%)
€16.50
12.01.20
-
04.11.21
114.55%
05.11.21

Probably not worthwhile Investment
Lokrim 
12.01.20 10%
buy
Gensight Biologics SA

Start price
Target price
Perf. (%)
€4.07
12.01.20
€8.50
04.11.21
35.92%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
12.01.20 50%
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€87.50
12.01.20
€155.00
04.11.21
170.06%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
12.01.20 50%
sell
Melinta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.44
06.01.20
-
09.01.20
1.35%
09.01.20

Quitte 
06.01.20 50%
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€2.80
04.01.20
-
04.11.21
112.50%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
04.01.20 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€83.00
22.12.19
€79.00
04.11.21
-3.61%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
geldnutzer 
22.12.19 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€18.00
21.12.19
€30.00
04.11.21
-36.06%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Maxi_Scalibusa 
21.12.19 60%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.38
20.12.19
€86.00
23.04.20
21.40%
23.04.20

stratec 
20.12.19 50%
buy
Adamas Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.46
17.12.19
€6.00
04.11.21
103.76%
05.11.21

tamam 
17.12.19 50%
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.94
10.12.19
€13.00
04.11.21
20.81%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
10.12.19 50%
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€9.50
27.11.19
€25.00
04.11.21
-16.00%
05.11.21

Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Schmiedseppe 
27.11.19 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€109.44
27.11.19
-
04.11.21
65.25%
16.10.21

Could be worthwhile Investment >10% per year
melinda 
27.11.19 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.29
25.11.19
-
04.11.21
196.12%
05.11.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Maxi_Scalibusa 
25.11.19 0%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€76.60
20.11.19
€85.00
04.11.21
4.44%
05.11.21

gerihouse 
20.11.19 50%
buy
AB Science S.A.

Start price
Target price
Perf. (%)
€5.24
15.11.19
€12.00
04.11.21
148.86%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
15.11.19 50%
buy
Vbi Vaccines Inc

Start price
Target price
Perf. (%)
-
14.11.19
€1.00
24.11.19
-
24.11.19

DomRuinart 
14.11.19 50%
buy
Myokardia Inc

Start price
Target price
Perf. (%)
€48.80
13.11.19
€202.00
04.11.21
291.39%
05.11.21

stratec 
13.11.19 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€19.29
12.11.19
€44.00
29.10.24
-25.95%
27.02.24

Subdi 
12.11.19 30%
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€9.85
07.11.19
€28.00
04.11.21
184.77%
05.11.21

Could be very worthwhile Investment >20% year
melinda 
07.11.19 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.00
06.11.19
€23.00
04.11.21
-46.11%
05.11.21

tamam 
06.11.19 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€73.20
01.11.19
€98.00
04.11.21
37.84%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
01.11.19 50%